Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third-quarter 2025 dividend of $0.43 per share. Alongside these developments, ...

Pfizer will pay a $0.43 quarterly dividend on September 2, 2025, maintaining its 347-quarter streak of shareholder payouts.

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

The world of investing involves uncertainty, volatility, and ever-changing macroeconomic conditions. In such scenarios, ...

With continued uncertainty over Washington's policy priorities plus a recent flare-up of geopolitical tensions in the Middle East, it seems like Wall Street may continue to focus on ...

Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing ...

Pfizer’s Q1 earnings call delivered a rollercoaster of cautious optimism. CEO Albert Bourla credited solid execution in ...

Manulife Philippines has partnered with Pfizer to promote disease awareness and patient education, as part of its Better Days ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

Key Points These ETFs are game changers if you want a mix of stability and high yields. Some of them provide double-digit ...

Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the period. Pfizer's dismal stock ...